A Prediction Rule for Occurrence of Chronic Thromboembolic Disease After Acute Pulmonary Embolism

Wei Xiong1, He Du2, Yong Luo3

  • 1Department of Pulmonary and Critical Care Medicine, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China; Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

PubMed

Insights

A new Prediction Rule for CTED (PRC) score helps predict chronic thromboembolic disease (CTED) after acute pulmonary embolism (PE) treatment. This tool aids in identifying patients at risk for CTED following anticoagulation therapy.

Area of Science:

  • Cardiology
  • Pulmonary Medicine
  • Clinical Prediction Models

Background:

  • Chronic thromboembolic disease (CTED) can occur despite standard anticoagulation for acute pulmonary embolism (PE).
  • No validated scoring system currently exists to predict CTED development post-PE treatment.

Purpose of the Study:

  • To develop and validate a prediction score for identifying patients at risk of CTED after acute PE.
  • To provide a tool for risk stratification in patients treated for acute PE.

Main Methods:

  • A Prediction Rule for CTED (PRC) score was developed in a cohort of 1,124 patients and validated in a separate cohort of 211 patients.
  • Both original and simplified versions of the PRC score were evaluated using various performance metrics.

Main Results:

  • The PRC score incorporates 10 risk factors including active cancer, autoimmune diseases, obesity, immobility, elevated D-dimer, PE with DVT, prior VTE, non-VTE thromboembolism, thrombophilia, and unprovoked VTE.
  • In validation, the original PRC score demonstrated high sensitivity (86.3%) and specificity (76.3%) with a C-index of 0.815, outperforming the DASH score.
  • The simplified PRC score also showed strong predictive performance, indicating its clinical utility.

Conclusions:

  • The developed Prediction Rule for CTED (PRC) score effectively predicts the likelihood of CTED occurrence.
  • The PRC score can aid clinicians in managing patients with acute PE by identifying those at higher risk for developing CTED.
Abstract

Related Concept Videos

Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
139
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
831
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
217
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
675